Loading…
Loading…
See exactly how PRN's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PRN and 80,000+ other tickers.
The Invesco Dorsey Wright Industrials Momentum ETF (referred to as the Fund) is designed to track the performance of the Dorsey Wright Industrials Technical Leaders Index (the Index). Typically, the Fund allocates a minimum of 90% of its total assets to the securities that constitute this underlying Index. The Index is formulated to identify industrial sector companies demonstrating robust relative strength, a key indicator of momentum. It is composed of at least 30 securities selected from the NASDAQ US Benchmark Index. In this context, relative strength measures a security's performance…
AI infrastructure spending, strong defense demand, and rising manufacturing activity have all helped to push the industrials sector higher this year. The benchmark Industrial Select Sector SPDR Fund NYSEARCA: XLI, which tracks a broad index of large S&P companies in the industrials sector, has returned more than 16% year to date (YTD), making it one of the top-performing sector-specific funds over that period.
Launched on October 12, 2006, the Invesco Dorsey Wright Industrials Momentum ETF (PRN) is a passively managed exchange traded fund designed to provide a broad exposure to the Industrials - Broad segment of the equity market.
TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, is pleased to announce that the TULSA Procedure™ will be highlighted in four oral presentations at the upcoming American Urological Association's (“AUA”) Annual Meeting in Washington, DC, in the session titled “Prostate Cancer: Localized: Ablative Therapy II” on May 16th from 1:00-3:00 p.m. ET. TULSA Procedure Talks at AUA2026 Ram A.
Profound Medical Corp. (PRN:CA) Shareholder/Analyst Call Prepared Remarks Transcript
Profound Medical Corp. (PRN:CA) Q1 2026 Earnings Call Transcript